Human papillomavirus infections in skin cancers

Biomedicine and Pharmacotherapy

Volumn 52, Issue 1, 1998, Pages 26-33

  De Villiers, E M ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

HPV; Normal skin; Skin cancer

Indexed keywords

CANCER IMMUNOLOGY; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMAN; PRIORITY JOURNAL; REVIEW; SKIN BIOPSY; SKIN CANCER; SUN EXPOSURE; ULTRAVIOLET RADIATION; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS ETIOLOGY; VIRUS INFECTION; WART VIRUS;

EID: 0031908043     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(97)86238-5     Document Type: Article

References (104)

1. 1 de Villiers E-M. HPV types in human disease. In : Gross G. von Krogh G, eds. Human Papillomavirus Infections in Dermatovenereology. New York : CRC Press ; 1997. p 101-15
2. 2 zur Hausen H. Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet 1994 ; 343 : 955-7
3. 3 zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1996 ; 1288 : F55-78
4. 4 Jablonska S, Dabrowski J, Jakubowicz K. Epidermodysplasia verruciformis as a model in studies on the role of papillomaviruses in oncogenesis. Cancer Res 1972 ; 32 : 583-9
5. 5 Glinski W, Obalek S, Jablonska S, Orth, G. T-cell defect in patients with epidermodysplasia verruciformis due to human papillomaviruses type 3 and 5. Dermatologica 1981 ; 162 : 141-7
6. 6 Majewski S, Malejczyk J, Jablonska S, Misiewicz, J, Rudnicka L, Obalek S, Orth G. Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis. J Am Acad Dermatol 1990 ; 22 : 423-7
7. 7 Majewski S, Jablonska S. Skin autografls in epidermodysplasia verruciformis : Human papillomavirus-associated cutaneous changes need over 20 years for malignant conversion. Cancer Res 1997 ; 57 : 4214-16
8. 8 Jablonska S. Epidermodysplasia verruciformis. In : Friedman RJ, ed. Skin Cancers. Philadelphia : WB Saunders Co ; 1991. p 101-13
9. 9 Orth, G. Epidermodysplasia verruciformis. In : Salzman HP, Howley PM, eds. The Papovaviridae. Vol 2. London : Plenum Press ; 1987. p 199-243
10. 10 Obalek S, Favre M, Szymanczyk J, Misiewicz J, Jablonska S, Orth G. Human papillomavirus (HPV) types specific of epidermodysplasia verruciformis detected in warts induced by HPV 3 or HPV 3 related types in immunosuppressed patients. J Invest Dermatol 1992 ; 98 : 936-41
11. 11 Adachi A, Kiyono T, Hayashi Y, Ohashi M, Ishibashi M. Detection of human papillomavirus (HPV) type 47 DNA in malignant lesions from epidermodysplasia verruciformis by protocols for precise typing of related HPV DNAs. J Clin Microbiol 1996 ; 34 : 369-75
12. 12 Kanda R, Tanigaki T, Kitano Y, Yoshikawa K, Yutsudo M, Hakura A. Types of human papillomavirus isolated from Japanese patients with epidermodysplasia verruciformis. Br J Dermatol 1989 ; 121 : 463-9
13. 13 Orth G. Epidermodysplasia verruciformis : a model for understanding the oncogenicity of human papillomaviruses. In: Ciba Foundation Symposium 120, ed. Papillomaviruses. Chichester : Wiley ; 1986. p 157-74
14. 14 Yutsudo M, Shimakage T, Hakura A. Human papillomavirus type 17 DNA in skin carcinoma tissue of a patient with epidermodysplasia verruciformis. Virology 1985 ; 144 : 295-8
15. 15 Yutsudo M, Tamgaki T, Kanda R, Sasagawa T, Inoue T, Jing P et al. Involvement of human papillomavirus type 20 in epidermodysplasia verruciformis skin carcinogenesis. J Clin Microbiol 1994 ; 32 : 1076-8
16. 16 Iftner T, Bierfelder S, Czapo Z, Pfister H. Involvement of human papillomavirus type 8 genes E6 and E7 in transformation and replication. J Virol 1988 ; 62 : 3655-61
17. 17 Hiraiwa A, Kiyono T, Segawa K, Utsumi KR, Ohashi M, Ishibashi M. Comparative study on E6 and E7 genes of some cutaneous and genital papillomaviruses of human origin for their ability to transform 3Y1 cells. Virology 1993 ; 192 : 102-11
18. 18 Kiyono T, Hiraiwa A, Ishibashi M. Differences in transforming activity and coded amino acid sequence among E6 genes of several papillomaviruses associated with epidermodysplasia verruciformis. Virology 1992 ; 186 : 628-39
19. 19 Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990 ; 63 : 1129-36
20. 20 Kiyono T, Hiraiwa A, Ishii S, Takahashi T, Ishibashi M. Inhibition of p53-mediated transactivation by E6 of type 1, but not type 5, 8, or 47, human papillomavirus of cutaneous origin. J Virol 1994 ; 68 : 4656-61
21. 21 Miller DL, Weinstock MA. Nonmelanoma skin cancel in the United States : Incidence. J Am Acad Dermatol 1994 ; 30 : 774-8
22. 22 Parker SL, long T, Bolden S, Wingo PA. Cancer Statistics, 1996. CA Cancer J Clin 1996 ; 65 : 5-27
23. 23 Marks R, Staples M, Giles GG. Trends in non-melanocytic skin cancer treated in Australia : The second national survey. Int J Cancer 1993 ; 53 : 585-90
24. 24 Frost CA, Green AC. Epidemiology of solar keratoses. Br J Dermatol 1994 ; 131 : 455-64
25. 25 Ko CB, Walton S, Keczkes K, Bury HPR, Nicholson C. The emerging epidemic of skin cancer. Br J Dermatol 1994 ; 130 : 269-72
26. 26 Gray DT, Suman VJ, Su WPD, Clay RP, Harmsen WS, Roenigk RK. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol 1997 ; 133 : 735-40
27. 27 Green A. Changing patterns in incidence of non-melanoma skin cancer. Epith Cell Biol 1992 ; 1 : 47-51
28. 28 Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA 1989 ; 262 : 2097-100
29. 29 Preston DS, Stern RS. Nonmelanoma cancers of the skin. New Engl J Med 1992 ; 327 : 1649-62
30. 30 Jablonska S, Majewski S. Epidermodysplasia verruciformis : Immunological and clinical aspects. Curr Top Microbiol Immunol 1994 ; 186 : 157-75
31. 31 Majewski S, Jablonska S. Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 1997 ; 36 : 659-85
32. 32 el Zein R, Shaw P, Tyring SK, Au WW. Chromosomal radiosensitivity of lymphocytes from skin cancer-prone patients. Mutat Res 1995 ; 335 : 143-9
33. 33 Au WW. Abnormal chromosome repair and risk of developing cancer. Environ Health Perspect 1993 ; 101 Suppl 3 : 303-8
34. 34 Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohmé I, Forsberg B et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 1995 ; 60: 183-9
35. 35 Bouwes Bavinck JN. Epidemiological aspects of immunosuppression : role of exposure to sunlight and human papillomavirus on the development of skin cancer. Hum Exper Toxicol 1995 ; 14 : 98
36. 36 Penn I. Skin disorders in organ transplant recipients : External anogenital lesions. Arch Dermatol 1997 ; 133 : 221-3
37. 37 Almog N, Rotter V. Involvement of p53 in cell differentiation and development. Biochim Biophys Acta 1997 ; 1333 : F1-27
38. 38 Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP et al. A role for sunlight in skin cancer : UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991 ; 88 : 10124-8
39. 39 Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 1993 ; 90 : 4216-20
40. 40 Pfeifer GP, Holmquist GP. Mutagenesis in the p53 gene. Biochim Biophys Acta 1997 ; 1333 : M1-8
41. 41 Li G, Ho VC, Tron VA. Ultraviolet radiation induction of squamous cell carcinomas in p53 transgenic mice. Cancer Res 1995 ; 55 : 2070-4
42. 42 McNutt NS, Saenz-Santamaria C, Volkenandt M, Shea CR, Albino AP. Abnormalities of p53 protein expression in cutaneous disorders. Arch Dermatol 1994 ; 130 : 225-32
43. 43 Rees JL. Genetic alterations in non-melanoma skin cancer. J Invest Dermatol 1994 ; 103 : 747-50
44. 44 Barnes DM, Hanby AM, Gillet CE, Mohammed S, Hodgson S, Bobrow LG et al. Abnormal expression of wild type p53 protein in normal cells of a cancer family patient. Lancet 1992 ; 340 : 259-63
45. 45 Campbell C, Quinn AG, Angus B, Rees JL. The relation between p53 mutation and p53 immunostaining in non-melanoma skin cancer. Br J Dermatol 1993 ; 129 : 235-41
46. 46 Pizarro A, Gamallo C, Castresana JS, Gomez L, Palacios J, Benito N et al. p53 expression in vital warts from patients with epidermodysplasia verruciformis. Br J Dermatol 1995 ; 132 : 513-19
47. 47 Lu X, Burbridge SA, Griffin S, Smith HM. Discordance between accumulated p53 protein level and its transcriptional activity in response to UV radiation. Oncogene 1996 ; 13 : 413-18
48. 48 de Villiers, E-M. Papillomavirus and HPV typing. In : Jablonska S, Orth G, eds. Clinics in Dermatology, Papillomaviruses. Vol 15. New York : Elsevier Science ; 1997. p 199-206
49. 49 Kawashima M, Jablonska S, Favre M, Obalek S, Croissant O, Orth G. Characterization of a new type of human papillomavirus found in a lesion of Bowens disease of the skin. J Virol 1986 ; 57 : 688-92
50. 50 Stone MS, Noonan CA, Tschen J, Bruce S. Bowens disease of the feet : presence of human papillomavirus 16 DNA in tumor tissue. Arch Dermatol 1987 ; 123 : 1517-20
51. 51 Kühnl-Petzold C, Grösser A, de Villiers E-M. HPV 16 assozierter bowenoid-verruköser Tumor der palmaren Haut. Akt Dermatol 1988 ; 14 : 848-9
52. 52 Ashinoff R, Li JJ, Jacobsen M, Friedman-Kien AE, Geronomus RG. Detection of human papillomavirus DNA in squamous cell carcinoma of the nail bed and finger determined by polymerase chain reaction. Arch Dermatol 1991 ; 127 : 1813-18
53. 53 Forslund O, Nordin P, Andersson K, Stenquist B, Hansson B-G. DNA analysis indicates patient-specific human papillomavirus type 16 strains in Bowens disease on fingers and in archival samples from genital dysplasia. Br J Dermatol 1997 ; 136 : 678-82
54. 54 Guitart J, Bergfeld WF, Tuthill RJ, Tubbs RR, Zienowicz, Fleegler EJ. Squamous cell carcinoma of the nail bed : a clinicopathological study of 12 cases. Br J Dermatol 1990 ; 123 : 215-22
55. 55 Kettler AH, Rutledge M, Tschen J, Buffone G. Detection of human papillomavirus in nongenital Bowens disease by in situ DNA hybridization. Arch Dermatol 1990 ; 126 : 777-81
56. 56 McGrae JD, Greer CE, Manos M. Multiple Bowens disease of the fingers associated with human papillomavirus type 16. Int J Dermatol 1993 ; 32 : 104-7
57. 57 Moy RL, Eliezri YD, Nuovo GJ, Zitelli JA. Bennett RG, Silverstein S. Human papillomavirus type 16 DNA in periungual squamous cell carcinomas. JAMA 1989 ; 261 : 2669-73
58. 58 Ostrow RS, Shaver K, Turnquist S, Viksnins A, Bender M, Vance C et al. Human papillomavirus-16 DNA in a cutaneous invasive cancer. Arch Dermatol 1989 ; 125 : 666-9
59. 59 Sau P, McMarlin SL, Sperling LC, Katz R. Bowens disease of the nail bed and periungual area. Arch Dermatol 1994 ; 130 : 204-9
60. 60 Venuti A, Donati P, Amantea A, Balus L. Human papillomavirus in non-genital Bowens disease and bowenoid carcinoma. Eur J Dermatol 1994 ; 4 : 142-7
61. 61 Fader DJ, Stoler MH, Anderson TF. Isolated extragenital HPV-thirties-group-positive bowenoid papulosis in an AIDS patient. Br J Dermatol 1994 ; 131 : 577-80
62. 62 McHugh RW, Hazen P, Eliezri YD, Nuovo GJ. Metastatic periungual squamous carcinoma : detection of human papillomavirus type 35 RNA in the digital tumor and axillary lymph node metastases. J Am Acad Dermatol 1996 ; 34 : 1080-2
63. 63 Rapini RP, Magee KL, Adler-Storthz K. The role of human papillomavirus in cutaneous neoplasia. Adv Dermatol 1991 ; 7 : 129-48
64. 64 Rudlinger R, Grob R, Yu YX, Schnyder UW, Human papillomavirus-35-positive bowenoid papulosis of the anogenital area and concurrent human papillomavirus-35-positive verruca with bowenoid dysplasia of the periungual area. Arch Dermatol 1989 ; 125 : 215-22
65. 65 Mitsuishi T, Sata T, Matsukura T, Iwasaki T, Kawashima M. The presence of mucosal human papillomavirus in Bowens disease of the hands. Cancer 1997 ; 79 : 1911-17
66. 66 Egawa K, Delius H, Matsukura T, Kawashima M, de Villiers E-M. Two novel types of human papillomavirus. HPV 63 and HPV 65 : comparisons of their clinical and histological features and DNA sequences to other HPV types. Virology 1993 ; 194 : 789-99
67. 67 de Villiers E-M. Implication of papillomaviruses in nongenital tumours. In : de Palo R, Rilke F, zur Hausen H, eds. Herpes and Papillomaviruses. New York : Raven Press, 1988 ; 65-70
68. 68 Inaba Y, Egawa K, Yoshimura K, Ono T. Demonstration of human papillomavirus type 1 DNA in a wart with bowenoid changes. Am J Dermatopathol 1993 ; 15 : 172-5
69. 69 Grußendorf-Conen, E-I. HPV-16-induzierte pigmentierte bowenoide Papulose am Hals. Akt Dermatol 1988 ; 14 : 317-19
70. 70 Hirt L, Hirsch-Behnam A, de Villiers E-M. Nucleotide sequence of human papillomavirus (HPV) type 41 : an unusual HPV type without a typical E2 binding site consensus sequence. Virus Res 1991 ; 18 : 179-90
71. 71 Kawashima M, Favre M, Jablonska S, Obalek S, Orth G. Characterization of a new type of human papillomavirus (HPV) related to HPV 5 from a case of actinic keratosis. Virology 1986 ; 154 : 389-94
72. 72 Scheurlen W, Gissmann L, Gross G, zur Hausen H. Molecular cloning of two new human papillomavirus types (HPV 37 and HPV 38) from a keratoakanthoma and a malignant melanoma. Int J Cancer 1986 ; 38 : 671-6
73. 73 Kawashima M, Favre M, Obalek S, Jablonska S, Orth G. Premalignant lesions and cancer of the skin in the general population : evaluation of the role of human papillomaviruses. J Invest Dermatol 1990 ; 95 : 537-42
74. 74 Shamanin V, zur Hausen H, Lavergne D, Proby CM, Leigh IM, Neumann C et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996 ; 88 : 802-11
75. 75 Maurer TA, Christian KV, Kerschmann RL, Berzin B, Palefsky JM, Payne D et al. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. Arch Dermatol 1997 ; 133 : 577-83
76. 76 Wang C-Y, Brodland DG, Su WPD. Skin cancers associated with acquired immunodeficiency syndrome. Mayo Clin Proc 1995 ; 70 : 766-72
77. 77 Leigh IM, Glover MT. Skin cancers and warts in immunosuppressed renal transplant recipients. Recent Results Cancer Res 1995 ; 139 : 69-86
78. 78 Van der Leest RJ, Zachow KR, Ostrow RS, Bender M, Pass F, Faras AJ. Human papillomavirus heterogeneity in 36 renal transplant recipients. Arch Dermatol 1987 ; 123 : 354-7
79. 79 Obalek S, Favre M, Jablonska S, Szymanczyk J, Orth G. Human papillomavirus type 2-associated basal cell carcinoma in two immunosuppressed patients. Arch Dermatol 1988 ; 124 : 930-4
80. 80 Barr BBB, Benton EC, McLaren K, Bunney MH, Smith IW, Blessing K, Hunter JAA. Human papillomavirus infection and skin cancer in renal allograft recipients. Lancet 1989 ; i : 124-9
81. 81 Soler C, Chardonnet Y, Euvrard S, Chignol MC, Thivolet J. Evaluation of human papillomavirus type 5 on frozen sections of multiple lesions from transplant recipients with in situ hybridization and non-isotopic probes. Dermatology 1992 ; 184 : 248-53
82. 82 Trenfield K, Salmond CA, Pope JH, Hardie IR. Southern blot analysis of skin biopsies for human papillomavirus DNA : renal allograft recipients in south-eastern Queensland. Australas J Dermatol 1993 ; 34 : 71-8
83. 83 Müller M, Kelly G, Fiedler M, Gissmann L. Human papillomavirus type 48. J Virol 1989 ; 63 : 4907-8
84. 84 Euvrard S, Chardonnet Y, Pouteil-Noble C, Kanitakis J, Chignol MC, Thivolet J, Touraine JL. Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients. Cancer 1993 ; 72 : 2198-206
85. 85 Soler C, Chardonnet Y, Allibert P, Euvrard S, Schmitt D, Mandrand B. Detection of mucosal human papillomavirus types 6/11 in cutaneous lesions from transplant recipients. J Invest Dermatol 1993 ; 101 : 286-91
86. 86 Stark LA, Arends MJ, McLaren KM, Benton EC, Shahidullah H, Hunter JAA, Bird CC. Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion. Br J Cancer 1994 ; 69 : 222-9
87. 87 Smith SE, Davis IC, Leshin B, Fleischer AB, White WL, Feldman SR. Absence of human papillomavirus in squamous cell carcinomas of nongenital skin from immunocompromised renal transplant patients. Arch Dermatol 1993 ; 129 : 1585-8
88. 88 Goldberg LH, Griego RD. Absence of human papillomavirus in squamous cell carcinomas of nongenital skin from immunocompromised renal transplant patients : a comment. Arch Dermatol 1995 ; 131 : 107
89. 89 Tieben LM, Berkhout RJM, Smits HL, Bouwes Bavinck JN, Vermeer BJ, Bruijn JA et al. Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients. Br J Dermatol 1994 ; 131 : 226-30
90. 90 Shamanin V, Delius H, de Villiers E-M. Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J Gen Virol 1994 ; 75 : 1149-56
91. 91 Shamanin V, Glover M, Rausch C, Proby C, Leigh IM, zur Hausen H, de Villiers E-M. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res 1994 ; 54 : 4610-13
92. 92 Berkhout RJM, Tieben LM, Smits HL, Bouwes Bavinck JN, Vermeer BJ, ter Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995 ; 33 : 690-5
93. 93 de Jong-Tieben LM, Berkhout RJM, Smits HL, Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, ter Schegget J. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 1995 ; 105 : 367-71
94. 94 Harris AJ, Purdie K. Leigh IM, Proby C, Burge S. A novel human papillomavirus identified in epidermodysplasia verruciformis. Br J Dermatol 1997 ; 136 : 587-91
95. 95 Höpfl R, Bens G, Wieland U, Petter A, Zelger B, Fritsch P, Pfister H. Human papillomavirus DNA in non-melanoma skin cancers of a renal transplant recipient : detection of a new sequence related to epidermodysplasia verruciformis associated types. J Invest Dermatol 1997 ; 108 : 53-6
96. 96 Noel JC, Detremmeric O, Peny MO, Candaele M, Verhest A, Heenen M, de Dobbeleer G. Transformation of common warts into squamous cell carcinoma on sun-exposed areas in an immunosuppressed patient. Dermatology 1994 ; 189 : 308-11
97. 97 de Villiers E-M, Lavergne D, McLaren K, Benton EC. Prevailing papillomavirus types in nonmelanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 1997 ; 73 : 356-61
98. 98 Boxman ILA, Berkhout RJM, Mulder LHC, Wolkers MC, Bouwes Bavinck JN, Vermeer BJ, ter Schegget J, Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997 ; 108 : 712-15
99. 99 Rohwedder A, Keminer O, Hendricks C, Schaller J. Detection of HPV DNA in trichilemmomas by polymerase chain reaction. J Med Virol 1997 ; 51 : 119-25
100. 100 Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 1995 ; 131 : 1312-18
101. 101 Rudlinger R, Smith IW, Bunney MH, Hunter JAA. Human papillomavirus infections in a group of renal transplant recipients. Br J Dermatol 1986 ; 115 : 681-92
102. 102 Maltzman WA, Czyzyk L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 1984 ; 4 : 1689-94
103. 103 Astori G, Lavergne D, Benton C, Höckmayr B, Egawa K, Garbe C, de Villiers E-M. Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol 1998. in press
104. 104 Delius H, Saegling B, Bergmann K, Shamanin V, de Villiers E-M. The genomes of three of four novel HPV types, defined by differences of their L1 genes, show high conservation of the E7 gene and the URR. Virology 1998, in press